Benign prostatic hyperplasia with lower urinary tract symptoms
ICD-10 N40.1 is a billable code used to indicate a diagnosis of benign prostatic hyperplasia with lower urinary tract symptoms.
Benign prostatic hyperplasia (BPH) is a common condition in older men characterized by the enlargement of the prostate gland, which can lead to various lower urinary tract symptoms (LUTS). These symptoms may include increased frequency of urination, urgency, nocturia, weak urinary stream, and difficulty starting or stopping urination. The condition is not cancerous but can significantly impact the quality of life. The pathophysiology of BPH involves hormonal changes, particularly the influence of dihydrotestosterone (DHT) on prostate tissue growth. Diagnosis typically involves a combination of patient history, physical examination, and tests such as the prostate-specific antigen (PSA) level, which helps rule out prostate cancer. Treatment options range from lifestyle modifications and medication to surgical interventions, depending on the severity of symptoms and the degree of obstruction. Accurate coding for N40.1 requires careful documentation of symptoms and any related procedures performed.
Detailed documentation of symptoms, PSA levels, and treatment plans.
Patients presenting with LUTS, follow-up visits post-treatment, and pre-operative evaluations.
Ensure that all relevant diagnostic tests and their results are documented to support the diagnosis.
Comprehensive patient history and symptom assessment.
Routine screenings for prostate health, management of chronic LUTS.
Document any referrals to urology and the rationale for such referrals.
Used for patients with severe BPH symptoms unresponsive to medication.
Document indication for surgery, pre-operative assessments, and post-operative care.
Urologists must ensure all procedural details are accurately captured.
Common symptoms include increased urinary frequency, urgency, nocturia, weak stream, and difficulty starting or stopping urination.
Diagnosis is typically made through patient history, physical examination, and tests such as PSA levels and possibly imaging studies.
Treatment options include lifestyle changes, medications like alpha-blockers and 5-alpha-reductase inhibitors, and surgical procedures such as TURP.
